499 related articles for article (PubMed ID: 20554593)
1. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
Ekbatani A; Asaro LR; Malinow AM
Int J Obstet Anesth; 2010 Jan; 19(1):82-7. PubMed ID: 19625181
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
4. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
He Y; He H; Liu D; Long Y; Su L; Cheng W
Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
[TBL] [Abstract][Full Text] [Related]
7. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD
Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236
[TBL] [Abstract][Full Text] [Related]
8. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
10. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
Willenborg KL
Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
[TBL] [Abstract][Full Text] [Related]
11. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
Gavranić BB; Basić-Jukić N; Kes P
Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
13. How we manage patients with heparin induced thrombocytopenia.
Scully M; Gates C; Neave L
Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
[TBL] [Abstract][Full Text] [Related]
14. [Open heart surgery using cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia(HIT)].
Furukawa H; Konishi T; Fukata M; Okada H; Sakagami N; Kurosaki K
Kyobu Geka; 2013 May; 66(5):383-6. PubMed ID: 23674036
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Warkentin TE
Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
[No Abstract] [Full Text] [Related]
16. Standardizing the management of heparin-induced thrombocytopenia.
Fugate S; Chiappe J
Am J Health Syst Pharm; 2008 Feb; 65(4):334-9. PubMed ID: 18238772
[TBL] [Abstract][Full Text] [Related]
17. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Hellwig TR; Peitz GJ; Gulseth MP
Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
19. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.
Brown P; Jay R; Fox A; Oliver M
Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938
[TBL] [Abstract][Full Text] [Related]
20. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
Efird LE; Kockler DR
Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
